1. November 2026

On Their Way…

Each month, the editors of three of the ASPET journals choose their Highlighted Trainee Authors. These early-career scientists are recognized for their innovative research published in The Journal of Pharmacology and Experimental Therapeutics, Drug Metabolism and Disposition, and Molecular Pharmacology. This feature showcases selected young scientists, demonstrates what drives them, and reveals why pharmacology is important to them. This month we are featuring the October 2026 Highlighted Trainee Author for Molecular Pharmacology.

Hossein Batebi, PhD

Hossein Batebi, PhD

Molecular Pharmacology

Hossein Batebi, PhD, is a Postdoctoral Researcher in the Physics Department at Freie Universität Berlin. He trained as a chemist and arrived at pharmacology through physics. “What moved me was a question chemistry could pose but not answer,” he said. “I could describe a drug and its target in full detail and still not say what the cell would do about it.” Throughout his journey within physics, his work often drifted to pharmacology—from receptor structures, to the dynamics that connect them, to the molecular kinetics underneath. Batebi credits Peter Hildebrand, Georgios Skiniotis, Brian Kobilka, and Roland Netz for their continued mentorship and collaboration.

Batebi’s research, “Structurome-wide analysis reveals intracellular loop 2 folding as an activation-associated feature of class A G protein-coupled receptors,” studies how signals travel through G protein-coupled receptors, the targets of roughly a third of approved medicines, and why two drugs binding the same receptor produce different cellular outcomes. His approach combines molecular simulation with theory for the parts that simulation cannot reach directly. Batebi developed a way to calculate how long a drug stays bound to its target, which could have timescales of minutes to hours.

“My work is about calculating those two timings on a computer before anyone does the experiment. If you can predict how long a drug will stay and how long the cell’s response takes, you can say in advance what kind of effect a new medicine will have, instead of finding out afterwards.” For painkillers in particular, that is the difference between the pain relief you want and the side effects you don’t.

For Batebi, being published in Molecular Pharmacology means a great deal. “Computational predictions are only worth the experiments they survive, and the readers of an ASPET journal are the people who run those experiments. Reaching them is the point.”